HDAC2 and hepatocellular carcinoma: Our data demonstrates a new mechanistic rule of aberrant epigenetic regulators in determining HCC cell fate under sorafenib-imposed selective pressure, in which the DNMT3a-TET2-HDAC2 complex modulates TSGs and cell proliferation genes through DNA methylation-dependent and -independent manners.